1. Home
  2. HBIO vs RDI Comparison

HBIO vs RDI Comparison

Compare HBIO & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$5.11

Market Cap

25.7M

Sector

Industrials

ML Signal

HOLD

RDI

Reading International Inc

HOLD

Current Price

$1.09

Market Cap

23.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBIO
RDI
Founded
1901
1937
Country
United States
United States
Employees
N/A
2025
Industry
Biotechnology: Laboratory Analytical Instruments
Movies/Entertainment
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
25.7M
23.6M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
HBIO
RDI
Price
$5.11
$1.09
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$15.30
N/A
AVG Volume (30 Days)
327.0K
20.6K
Earning Date
06-15-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$116,176,000.00
N/A
Revenue This Year
$9.13
N/A
Revenue Next Year
$4.21
$13.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.94
52 Week High
$0.95
$1.65

Technical Indicators

Market Signals
Indicator
HBIO
RDI
Relative Strength Index (RSI) 96.73 51.86
Support Level $0.46 $1.07
Resistance Level N/A $1.16
Average True Range (ATR) 0.10 0.06
MACD 0.28 0.01
Stochastic Oscillator 95.68 74.36

Price Performance

Historical Comparison
HBIO
RDI

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

About RDI Reading International Inc

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

Share on Social Networks: